MCM
TVTX icon

Matarin Capital Management’s Travere Therapeutics TVTX Stock Holding History

Matarin Capital Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.32M Buy
48,372
+36,884
+321% +$861K 0.32% 130
2020
Q3 		$212K Buy
+11,488
New +$223K 0.04% 193
2018
Q2 		– Sell
-22,632
Closed -$506K – 326
2018
Q1 		$506K Sell
22,632
-2,723
-11% -$64.8K 0.04% 246
2017
Q4 		$534K Hold
25,355
– – 0.04% 244
2017
Q3 		$631K Hold
25,355
– – 0.05% 227
2017
Q2 		$492K Buy
25,355
+2,333
+10% +$42.3K 0.05% 223
2017
Q1 		$425K Buy
+23,022
New +$450K 0.04% 230

Other funds holding TVTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return